Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren
Description
IKK classic hereby announces that it will conclude non-exclusive discount agreements in accordance with § 130a para 8 SGB V on equal, non-negotiable terms with all interested and suitable pharmaceutical companies for various active substances and active substance combinations for the period from 01.11.2026 to 31.10.2028. The earliest contract start date is 01.11.2026, provided that the signed contract and all necessary evidence, declarations and documents are received by IKK classic by 05.10.2026. Thereafter, the following applies: If the documents are received by the 05th of a respective month in the possible entry period, the 01st of the following month will be the contract start date. If the documents are received after the 05th of a respective month in the possible entry period, the 01st of the second following month will be the contract start date. Entry into the agreement is possible at any time during the specified period, but at the latest by 05.09.2028. Further details see section VI.3.
CPV codes
Documents & submission
Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Related tenders
Germany – Medical furniture – Wagen - Behandlung - Pflege - Narkose etc.
Klinikum Main-SpessartGermanyMedical furnitureMedical equipmentsDeadline in 42 daysPublished on Nov 01, 2026
Germany – Gas-therapy and respiratory devices – Beatmung Neonatologie Klinikum Oldenburg
Klinikum Oldenburg AöRGermanyGas-therapy and respiratory devicesDeadline in 24 daysPublished on Nov 01, 2026
Germany – Diagnostic systems – Laborautomation
Universitätsklinikum Hamburg-EppendorfGermanyDiagnostic systemsNo deadline givenPublished on Nov 01, 2026
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 29 Rituximab (nur Fertigarzneimittel)
Techniker KrankenkasseGermanyPharmaceutical productsDeadline in 759 daysPublished on Nov 01, 2026